Literature DB >> 11736973

Impact of total mesorectal excision on the results of surgery of distal rectal cancer.

W L Law1, K W Chu.   

Abstract

BACKGROUND: This study reviewed the results of surgery for distal rectal cancer (tumours within 6 cm of the anal verge) following the introduction of total mesorectal excision for rectal cancer in one institution.
METHODS: Two hundred and five patients who had undergone surgical resection of rectal cancer within 6 cm of the anal verge were included. The demographic, operative and follow-up data were collected prospectively. Comparisons were made between patients who had different surgical procedures.
RESULTS: Abdominoperineal resection (APR) was performed in 27.8 per cent of patients, falling from 36.0 per cent in the first 3 years to 20.0 per cent in the last 3 years of the study. The overall operative mortality rate was 1.5 per cent and the morbidity rate 30.2 per cent. With a mean follow-up of 36 months, local recurrence occurred in 28 of the 185 patients who had curative resection. The 5-year actuarial local recurrence rates for double-stapled anastomosis, peranal coloanal anastomosis and APR were 11.2, 34.6 and 23.5 per cent respectively. The local recurrence rate was significantly lower for double-stapled low anterior resection than for the other types of operation. The overall 5-year survival rate in patients with low anterior resection and APR was 69.1 and 51.1 per cent respectively (P = 0.12).
CONCLUSION: With the practice of total mesorectal excision, APR was necessary in only 27.8 per cent of patients with rectal cancer within 6 cm of the anal verge. The local recurrence rate was much lower in patients with double-stapled low anterior resection than in those treated with APR or peranal anastomosis.

Entities:  

Mesh:

Year:  2001        PMID: 11736973     DOI: 10.1046/j.0007-1323.2001.01929.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  28 in total

1.  Laparoscopic total mesorectal excision of low rectal cancer with preservation of anal sphincter: a report of 82 cases.

Authors:  Zong-Guang Zhou; Zhao Wang; Yong-Yang Yu; Ye Shu; Zhong Cheng; Li Li; Wen-Zhang Lei; Tian-Cai Wang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

Review 2.  Total Mesorectal Excision Technique-Past, Present, and Future.

Authors:  Joep Knol; Deborah S Keller
Journal:  Clin Colon Rectal Surg       Date:  2020-04-28

3.  Long-term functional outcome of colonic J-pouch reconstruction after low anterior resection for rectal cancer.

Authors:  Jin-Ichi Hida; Takehito Yoshifuji; Kiyotaka Okuno; Tomohiko Matsuzaki; Toshihiro Uchida; Eizaburou Ishimaru; Tadao Tokoro; Masayuki Yasutomi; Hitoshi Shiozaki
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

4.  Outcomes of surgery for mid and distal rectal cancer in the elderly.

Authors:  Wai Lun Law; Hok Kwok Choi; Judy Wc Ho; Yee Man Lee; Chi Leung Seto
Journal:  World J Surg       Date:  2006-04       Impact factor: 3.352

5.  Applications of computed tomography pelvimetry and clinical-pathological parameters in sphincter preservation of mid-low rectal cancer.

Authors:  Xiaocong Zhou; Meng Su; Keqiong Hu; Yinfa Su; Yinghai Ye; Chongquan Huang; Zhenlei Yu; Xiaoyang Li; Hong Zhou; Yaozhong Ni; Yi Jiang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

6.  Total mesorectal excision: what are we doing?

Authors:  David B Stewart; David W Dietz
Journal:  Clin Colon Rectal Surg       Date:  2007-08

7.  Changes in treatment of rectal cancer: increased use of low anterior resection.

Authors:  A Mekras; A Michalopoulos; V N Papadopoulos; D Mekras; V Kalles; I Tzeveleki; G Dabakis; S Netta; G Basdanis
Journal:  Tech Coloproctol       Date:  2011-10       Impact factor: 3.781

8.  Multidisciplinary teams in the management of rectal cancer.

Authors:  Vincent J Obias; Harry L Reynolds
Journal:  Clin Colon Rectal Surg       Date:  2007-08

9.  Comparative evaluation of immune response after laparoscopical and open total mesorectal excisions with anal sphincter preservation in patients with rectal cancer.

Authors:  Jian-Kun Hu; Zong-Guang Zhou; Zhi-Xin Chen; Lan-Lan Wang; Yong-Yang Yu; Jin Liu; Bo Zhang; Li Li; Ye Shu; Jia-Ping Chen
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

10.  Impact of neoadjuvant treatment on total mesorectal excision for ultra-low rectal cancers.

Authors:  Yon Kuei Lim; Wai Lun Law; Rico Liu; Jensen T C Poon; Joe F M Fan; Oswens S H Lo
Journal:  World J Surg Oncol       Date:  2010-03-26       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.